About: Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by M. Hoffmann et al published 30 May 2007 in Drug Metabolism and Disposition

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2007 (uk) article scientifique publié en 2007 (fr) im Mai 2007 veröffentlichter wissenschaftlicher Artikel (de) article by M. Hoffmann et al published 30 May 2007 in Drug Metabolism and Disposition (en)
publication date	wds:Q56699026-16E07C0B-CD5A-4B8A-A64C-C3131265CAE2
publication date	2007-05-30 00:00:00Z (xsd:dateTime)
author name string	wds:Q56699026-0ABD59D9-360E-4EC2-8075-ABFC8668B25E wds:Q56699026-5BC925BB-C83F-417D-A496-0F6868D6FC51 wds:Q56699026-61824910-99F6-4484-825C-631FB55C7175 wds:Q56699026-68E84313-5D04-4E65-8FAE-48AFA66641F8 wds:Q56699026-7C43A7D5-D867-497F-84D6-0923B730B47D wds:Q56699026-90EA94CF-F28F-43EE-A3B2-A03E036DBB76 wds:Q56699026-C12AA547-B369-4EA1-A95B-1DD839046613
author name string	D. Harper M. Hoffmann R. A. Jordan J. Speth J. Scatina R. Talaat W. DeMaio
rdfs:label	Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects (en) Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects (nl)
skos:prefLabel	Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects (en) Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects (nl)
name	Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects (en) Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects (nl)
title	wds:Q56699026-EF8E1870-0AF2-4584-8282-88327AA8E9FD
title	Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects (en)
page(s)	wds:Q56699026-8574B74D-5C00-4B9F-953B-E198C9AC4EA4
page(s)	1543-1553
instance of	wds:Q56699026-C2D6388E-60DE-4467-BAB4-94D2F8E8D9FC
instance of	scholarly article
main subject	wds:Q56699026-DF2DAEA0-B49B-44AE-B972-855365F601F1
main subject	pharmacokinetics
PubMed ID	wds:Q56699026-87014747-FFD8-4B03-87DB-44F40B2FC6AB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17537869
PubMed ID	17537869
published in	wds:Q56699026-70016BBA-0B75-49F1-BB22-2262CC4E4465
published in	Drug Metabolism and Disposition
issue	wds:Q56699026-A0909BF8-BB40-4AB0-9764-594C8A7F2EBB
volume	wds:Q56699026-BDE8359A-7396-497B-979D-BFBAB853C3D4
issue	9
volume	35
DOI	wds:Q56699026-EA070D3F-6B72-4B5C-96C1-D08E93CC06A2
DOI	http://dx.doi.org/10.1124/DMD.107.015735
DOI	10.1124/DMD.107.015735
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56699026
is cites work of	Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile. 2013 WSES guidelines for management of intra-abdominal infections A review of tigecycline--the first glycylcycline Tigecycline: in community-acquired pneumonia Pancreatitis in tigecycline Phase 3 and 4 clinical studies Pharmacokinetic and pharmacodynamic evaluation of tigecycline Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection WSES consensus conference: Guidelines for first-line management of intra-abdominal infections Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of 14C-Omadacycline in Rats Tigecycline for the treatment of severe Clostridium difficile infection Pharmacokinetics and safety of a single intravenous dose of the antibiotic tigecycline in patients with cirrhosis Making methods rugged for regulated bioanalysis Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline. Tigecycline pharmacokinetics, tolerability, safety, and effect on intestinal microflora in healthy Japanese male subjects Clinical pharmacokinetics and pharmacodynamics of tigecycline Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review Transformation of tetracycline by TetX and its subsequent degradation in a heterologous host Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin High serum concentrations of cyclosporin related to administration of tigecycline Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae Evaluation of a potential tigecycline-warfarin drug interaction Population pharmacokinetics of high-dose tigecycline in patients with sepsis or septic shock. Radiolabeled mass-balance excretion and metabolism studies in laboratory animals: a commentary on why they are still necessary Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of tigecycline in rat brain tissues. Tigecycline and cyclosporine interaction-an interesting case of biliary-excreted drug enhancing the oral bioavailability of cyclosporine Pharmacokinetics of tigecycline in turkeys following different routes of administration. Tigecycline Interferes with Fibrinogen Polymerization Independent of Peripheral Interactions with the Coagulation System
is cites work of	wds:Q34726133-71A6E2B3-2E94-42A2-B202-841215AEEAAA wds:Q34321150-F2062C83-FA18-45FB-9B10-6387B899FD11 wds:Q38453213-28A699DE-9C93-42D4-AC94-3CD30EF5E0CA wds:Q40035130-773D1146-D5AD-44BA-A9A1-4924FB4ED6DA wds:Q35167183-D6BAB1A9-94A6-43E1-9CB9-6414882488ED wds:Q37897819-DAA6E5EF-B4C2-460D-A3EA-C744A3988843 wds:Q46720266-EEABF133-66E1-419C-8227-24BBCD5A0E15 wds:Q35026616-7DE9F5CC-5AB8-4FD2-AE16-3A2F3ED47134 wds:Q35959546-2198DC39-FBA9-4B3C-9E03-2620FAE7B363 wds:Q35045248-F41E2EC4-FF2A-446A-A4B5-A296F21D3FE2 wds:Q34602922-ED7D38AB-8B39-4571-B5E1-7E6F4CC67D64 wds:Q46555222-FB6347B4-7E76-4FB1-97BA-6AA09B88EB17 wds:Q51587016-500B8C4B-7A70-46E8-A94B-BD02F533FB55 wds:Q26823357-10A2BC56-2111-4B3C-814F-A1F971A82F1D wds:Q46364743-8FFE4EDA-37BE-467A-B987-915CF0402E57 wds:Q38026891-910304C1-5697-45AB-854A-D6048615EC1D wds:Q38088261-9F191C09-6AEE-46EB-9CC1-EF1055EEC4EE wds:Q37940546-69DA0F25-6DC4-4931-8781-D1408DB89187 wds:Q46118762-1A24F725-0BF9-4145-933E-6950845C067F wds:Q34710552-1291DABE-3097-4CE9-AE26-DB5B8C1996F8 wds:Q34541183-F3B8DBFD-1083-4A3B-8E55-A08D1C03B263 wds:Q35778366-4C354FA8-1130-4325-8624-193676ABE5D0

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software